Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2008;39:1869-1874
Published online before print April 10, 2008, doi: 10.1161/STROKEAHA.107.506022
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
39/6/1869    most recent
STROKEAHA.107.506022v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Wang, X.
Right arrow Articles by Lo, E. H.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, X.
Right arrow Articles by Lo, E. H.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Nucleotide
*Protein*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*MALONALDEHYDE
Related Collections
Right arrow Acute Cerebral Infarction
Right arrow Neuroprotectors

(Stroke. 2008;39:1869.)
© 2008 American Heart Association, Inc.


Original Contributions

Effects of Neuroglobin Overexpression on Acute Brain Injury and Long-Term Outcomes After Focal Cerebral Ischemia

Xiaoying Wang, MD, PhD; Jianxiang Liu, PhD; Haihao Zhu, MD, PhD; Emiri Tejima, MD; Kiyoshi Tsuji, MD; Yoshihiro Murata, MD; Dmitriy N. Atochin, PhD; Paul L. Huang, MD, PhD; Chenggang Zhang, PhD Eng H. Lo, PhD

From the Neuroprotection Research Laboratory, Departments of Neurology and Radiology (X.W., J.L., H.Z., E.T., K.T., Y.M., E.H.L.), Massachusetts General Hospital and the Program in Neuroscience, Harvard Medical School, Boston, Mass; the Cardiovascular Research Center (D.N.A., P.L.H.), Massachusetts General Hospital, Harvard Medical School, Boston, Mass; and the Department of Molecular Neurobiology (C.Z.), Beijing Institute of Radiation Medicine, Beijing, China.

Correspondence to Xiaoying Wang, MD, PhD, Neuroprotection Research Laboratory, Departments of Neurology and Radiology, Massachusetts General Hospital, 149 13th Street, Room 2411A, Charlestown, MA 02129. E-mail wangxi{at}helix.mgh.harvard.edu

Background and Purpose— Emerging data suggest that neuroglobin (Ngb) may protect against hypoxic/ischemic neuronal insults. However, the underlying mechanisms in vivo and implications for long-term outcomes are still not well understood.

Methods— Using our newly created Ngb overexpressing transgenic (Ngb-Tg) mice, we measured brain infarction on day 1 and day 14 after transient focal cerebral ischemia and performed neurobehavioral assessments in sensorimotor deficits on days 1, 3, 7, and 14. To test the hypothesis that Ngb may play a role in reducing oxidative stress after stroke, intracellular malondialdehyde levels were measured and compared in Ngb-Tg and wild-type mice.

Results— Increased Ngb mRNA and protein levels were identified in Ngb-Tg brains. Malondialdehyde levels in ischemic hemispheres of Ngb-Tg were significantly reduced compared with wild-type controls at 8 hours and 22 hours after transient focal cerebral ischemia. Compared with wild-type controls, brain infarction volumes 1 day and 14 days after transient focal cerebral ischemia were significantly reduced in Ngb-Tg mice. However, there were no significant improvements in sensorimotor deficits for up to 14 days after stroke in Ngb-Tg mice compared with wild-type controls.

Conclusions— Ngb reduces tissue infarction and markers of oxidative stress after stroke. Tissue protection by overexpressing Ngb can be sustained for up to 2 weeks.


Key Words: neuroglobin • neuroprotection • oxidative stress • stroke